Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Biondi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|May 24, 2020
Location First: Targeting Acute Myeloid Leukemia Within Its NicheAlice Pievani, Marta Biondi, Chiara Tomasoni, et al.
Journal for Immunotherapy of Cancer|January 31, 2024
CARs are sharpening their weaponsAlice Pievani, Marta Biondi, Sarah Tettamanti, et al.
Frontiers in Immunology|June 18, 2024
Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapiesAntonio Maria Alviano, Marta Biondi, Erica Grassenis, et al.
Frontiers in Immunology|July 9, 2020
Next-Generation Manufacturing Protocols Enriching T<sub>SCM</sub> CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer PatientsSilvia Arcangeli, Laura Falcone, Barbara Camisa, et al.
Blood|February 14, 2023
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burdenMarta Biondi, Sarah Tettamanti, Stefania Galimberti, et al.
Blood|June 5, 2026
High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemiaGianpietro Dotti, Tara Walhart, Marta Biondi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|May 24, 2020
Location First: Targeting Acute Myeloid Leukemia Within Its NicheAlice Pievani, Marta Biondi, Chiara Tomasoni, et al.
Journal for Immunotherapy of Cancer|January 31, 2024
CARs are sharpening their weaponsAlice Pievani, Marta Biondi, Sarah Tettamanti, et al.
Frontiers in Immunology|June 18, 2024
Fully equipped CARs to address tumor heterogeneity, enhance safety, and improve the functionality of cellular immunotherapiesAntonio Maria Alviano, Marta Biondi, Erica Grassenis, et al.
Frontiers in Immunology|July 9, 2020
Next-Generation Manufacturing Protocols Enriching T<sub>SCM</sub> CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer PatientsSilvia Arcangeli, Laura Falcone, Barbara Camisa, et al.
Blood|February 14, 2023
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burdenMarta Biondi, Sarah Tettamanti, Stefania Galimberti, et al.
Blood|June 5, 2026
High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemiaGianpietro Dotti, Tara Walhart, Marta Biondi, et al.
Pageof 1